March 2019 Briefing – Rheumatology
Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for March 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Patients With Worse RA Symptoms More Likely to […]
Read More